Additional Information
Size: |
100 µl |
Target: |
Vimentin |
Conjugate: |
APC/Cy7 |
Research Area: |
Neuroscience | Neurogenesis | Cell Signaling | Cytoskeleton | Intermediate Filaments | Vimentin | Neuroscience | Cell Markers | Neuron Markers | Neural Stem Cell Markers | Stem Cells | Lineage Markers | Endoderm | Cancer | Tumor Biomarkers | Neuroreg |
Alternative Name: |
CTRCT30 Antibody, Epididymis luminal protein 113 Antibody, HEL113 Antibody, VIM Antibody, VIME_HUMAN Antibody, Vimentin Antibody |
Category: |
Antibodies |
Product Type: |
Polyclonal Antibody |
Immunogen: |
Synthesized peptide derived from Internal of human vimentin. |
Immunogen Species: |
Human |
Applications: |
WB, IHC, ELISA |
Host: |
Rabbit |
Isotype: |
IgG |
Species Reactivity: |
Human, Mouse, Rat |
Antibody Dilution: |
WB (1:1000), IHC (1:100), ELISA (1:10000); optimal dilutions for assays should be determined by the user. |
Purification: |
Peptide Affinity Purified |
Storage Buffer: |
PBS pH 7.4, 50% glycerol, 150mM NaCl, 0.02% sodium azide |
Concentration: |
N/A |
Specificity: |
Detects ~53kDa, endogenous levels of total vimentin protein. |
Storage: |
-20ºC |
Shipping: |
Blue Ice or 4ºC |
Certificate of Analysis: |
A 1:1000 dilution of SPC-1338 was sufficient for detection of Vimentin in 10 µg of HepG2 cell lysates by ECL immunoblot analysis using Goat Anti-Rabbit IgG:HRP as the secondary antibody. |
Cellular Localization: |
Cytoplasm |
Tissue Specificity: |
Highly expressed in fibroblasts, some expression in T- and B-lymphocytes, and little or no expression in Burkitt's lymphoma cell lines. Expressed in many hormone-independent mammary carcinoma cell lines. |
Accession Number: |
NP_003371.2 |
Gene ID: |
7431 |
Swiss-Prot: |
P08670 |
Field of Use: |
For in vitro research use only. |